Credit Suisse plans 9% autocallable reverse convertibles tied to Celgene

By Jennifer Chiou

New York, Nov. 6 - Credit Suisse AG plans to price 9% autocallable reverse convertible securities due Nov. 20, 2014 linked to Celgene Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable monthly.

The notes will be called at par if the stock closes at or above the initial share price on any quarter;y observation date beginning on Feb. 14, 2014.

The payout at maturity will be par unless Celgene shares fall and ever close below the 70% knock-in level during the life of the notes, in which case the payout will be $1,000 divided by the initial share price.

The notes (Cusip: 22547QDG8) are expected to price on Nov. 15 and settle on Nov. 20.

Credit Suisse Securities (USA) LLC is the agent.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.